Displaying 69 Switzerland Biotech companies
 Filter
City
Country
Stage
Business Model
Industry
company score funding investors employees industries biz model city contact
NeurosterixJUST ADDED

Advanced allosteric modulator therapeutics developer for neurological disorders.

59
$63M · Series A Xontogeny, Perceptive Advisors, Acorn Bioventures 1 to 10 Health Tech, Biotech Geneva, Switzerland •••••••••••@neurosterix.com
LimulaJUST ADDED HIRING

Gene therapy platform.

54
$6M · Seed Life Extension Ventures, Zühlke Group, Oxford Seed Fund 1 to 10 Health Tech, Biotech Geneva, Switzerland •••••••••••@limula.ch
Nouscom

Viral vector-based cancer vaccines developer.

51
$82M · Series C Bpifrance, 5AM Ventures, Abingworth 1 to 10 Health Tech, Biotech B2C Basel, Switzerland •••••••••••@nouscom.com
BioVersys HIRING

Novel antiobiotic researcher to fight antimicrobial resistance.

46
$13M · Series C AMR Action Fund, GSK 1 to 10 Biotech, Pharma B2B Basel, Switzerland •••••••••••@bioversys.com
Stalicla

Precision medicine developer for neuropsychiatric and neurological disorders.

43
$13M · Series B SPRIM Global Investments 11 to 50 Biotech Geneva, Switzerland •••••••••••@stalicla.com
Memo Therapeutics

Antibody discovery and human immune repertoire analysis platform.

43
$27M · Series C Vesalius Biocapital Partners, Swisscanto Private Equity, Pureos Bioventures 11 to 50 Health Tech, Biotech B2B Zürich, Switzerland •••••••••••@memo-therapeutics.com
TOLREMO therapeutics

Developer of small molecules to treat novel drug resistance pathways in cancer therapy.

43
$20M · Series A Altos Ventures, BioMedPartners, Redalpine 1 to 10 Health Tech, Biotech Zürich, Switzerland •••••••••••@tolremo.com
Anjarium Biosciences

Gene therapy research to tackle genetic diseases.

43
$59M · Series A Gimv 1 to 10 Health Tech, Biotech, Pharma B2B Zürich, Switzerland •••••••••••@anjarium.com
Cradle

Generative AI platform for protein design and engineering.

43
$24M · Series A Index Ventures, Kindred Capital 11 to 50 AI, Biotech B2B Zürich, Switzerland •••••••••••@cradle.bio
Vandria

Small molecule mitophagy inducers developer.

42
$20M · Series A ND Capital 1 to 10 Health Tech, Biotech Lausanne, Switzerland •••••••••••@vandria.com
Allegria TherapeuticsJUST ADDED HIRING

Therapeutics developer for mast cell-mediated diseases.

42
$3M · Seed Forty51 Ventures 1 to 10 Health Tech, Biotech Basel, Switzerland •••••••••••@allegriatx.com
EBAMed

Non-invasive treatment for heart arrhythmias.

39
$15M · Series A EIC Accelerator, Panakes Partners 1 to 10 Health Tech, Biotech B2B Geneva, Switzerland •••••••••••@eba-med.com
LimmaTech Biologics

Self-adjuvanting and multi-antigen vaccine technology platform.

39
$3M · Series A AXA Investment Managers, Novo A/S, Adjuvant Capital 11 to 50 Health Tech, Biotech Zürich, Switzerland •••••••••••@lmtbio.com
GlycoEra

Glycanengineering platform.

39
$49M · Series A Sofinnova Partners 11 to 50 Health Tech, Biotech, Pharma B2B Zürich, Switzerland •••••••••••@glycoera.com
Noema Pharma

Clinical-stage central nervous system (CNS) technology.

37
$110M · Series B Sofinnova Partners, Forbion Capital Partners, BioMedPartners 1 to 10 Health Tech, Biotech, Pharma B2B Basel, Switzerland •••••••••••@noemapharma.com
Alithea Genomics

RNA sequencing and transcriptomics analysis platform.

37
$3M · Seed Novalis Biotechnology Incubation, TechU Ventures, Foundation for Technological Innovation (FIT) 1 to 10 Health Tech, Biotech B2B Lausanne, Switzerland •••••••••••@alitheagenomics.com
MindMaze

Platform providing digital assessments and therapies for patient treatment and rehabilitation.

37
$125M Hambro Perks Ltd. 101 to 250 Health Tech, AR / VR, Biotech, Deep Tech, Business Intelligence B2B Lausanne, Switzerland •••••••••••@mindmaze.com
Planetary

Biotech company creating meat and dairy alternatives using biomass and precision fermentation techniques.

34
$8M · Seed XAnge, Astanor Ventures, Nucleus Capital 11 to 50 Foodtech, Biotech, Manufacturing B2B Geneva, Switzerland •••••••••••@planetarygroup.ch
Microcaps HIRING

Producer of ethanol-free perfume pearls.

34
$10M · Series A Helvetica Capital, Zürcher Kantonal Bank, ETH Zurich Foundation 11 to 50 Biotech, Manufacturing B2C Zürich, Switzerland •••••••••••@microcaps.ch
iOnctura HIRING

Clinical-stage biotechnology developing treatments for cancer.

34
$85M · Series B EIC Accelerator, Syncona Partners LLP, M Ventures 11 to 50 Health Tech, Biotech Geneva, Switzerland •••••••••••@ionctura.com
Isospec Analytics SAJUST ADDED HIRING

Molecular analysis technology developer.

31
$1M · Pre Seed Tiny VC, another.vc, Founderful 1 to 10 Biotech B2B Lausanne, Switzerland •••••••••••@isospecanalytics.com
Epiterna

Manufacturer of drugs to combat the effects of ageing.

31
$10M · Series A Prima Materia 11 to 50 Health Tech, Biotech B2C Lausanne, Switzerland •••••••••••@epiterna.com
Aesyra

Accurate monitoring and treatment platform for sleep bruxism and sleep apnea.

31
$3M · Seed Zürcher Kantonal Bank, Supermoon Capital, Creadd Ventures 1 to 10 Health Tech, Biotech Lausanne, Switzerland •••••••••••@aesyra.com
Invasight

Clinical biotech firm focused on revolutionizing cell invasion research.

29
$4M · Seed High-Tech Gründerfonds, Verve Ventures 1 to 10 Health Tech, Biotech, Deep Tech B2B Zürich, Switzerland •••••••••••@invasight.com
Engimmune Therapeutics

Platform engineering next-generation T cell receptor therapies.

26
$15M · Seed Novo A/S, Pureos Bioventures 1 to 10 Health Tech, Biotech, Manufacturing B2B Basel, Switzerland •••••••••••@engimmune.com
Nanolive

Platform for observing live cells in 3D without damaging them.

26
$20M Swisscom Ventures 1 to 10 Health Tech, Biotech, Pharma, Manufacturing, Business Intelligence B2B, SaaS Lausanne, Switzerland •••••••••••@nanolive.ch
Biolytica

Program to increase human lifespan.

26
$5M · Seed Maximon 11 to 50 Health Tech, Biotech B2C Zug, Switzerland •••••••••••@biolytica.com
Araris Biotech

Developer of an antibody-drug conjugates (ADCs).

25
$110k · Pre Seed btov Partners, Pureos Bioventures, Redalpine 1 to 10 Health Tech, Biotech B2B Zürich, Switzerland •••••••••••@ararisbiotech.com
MPC Therapeutics

Compounds for immunotherapy and metabolic diseases.

25
$1M · Seed Plutus Investment Group 1 to 10 Biotech Geneva, Switzerland •••••••••••@mpc-therapeutics.com
Rejuveron Life Sciences

Biotechnology platform developing therapies by investing in people and ideas.

25
$25M · Series A 1 to 10 Health Tech, Fintech, Biotech, Pharma B2B Zürich, Switzerland •••••••••••@rejuveron.com
Groam

Bio-based and biodegradable foam solutions for fast disposables.

25
$161k · Pre Seed Venture Kick Agritech, Biotech, Energy & Nuclear, Manufacturing B2B Zürich, Switzerland •••••••••••@groamtech.com
ImmunOs Therapeutics

Immunotherapy platform for cancer.

25
$330k · Pre Seed Lightspeed Venture Partners, Gimv, BioMedPartners 11 to 50 Health Tech, Biotech, Pharma B2B Zürich, Switzerland •••••••••••@immunostherapeutics.com
BC Platforms

Platform offering tools to enhance the development of personalized and precision medicine.

25
$20M 51 to 100 Health Tech, Biotech, Deep Tech, Pharma, Data and Analytics, Business Intelligence B2B, SaaS Zürich, Switzerland •••••••••••@bcplatforms.com
Neurosoft Bioelectronics

Platform creating soft implantable electrodes for nervous system interfaces.

25
$169k · Pre Seed Venture Kick 1 to 10 Health Tech, Hardware, Biotech, Deep Tech, Manufacturing B2B Geneva, Switzerland •••••••••••@neurosoft-bio.com
Pharvaris

Clinical stage developer focused on providing an oral treatment for patients using a bradykinin B2 receptor antagonist.

23
$80M · Series C 11 to 50 Health Tech, Biotech, Deep Tech, Pharma B2B Zug, Switzerland •••••••••••@pharvaris.com
NewBiologix

Gene and cell therapy manufacturing.

23
$50M · Series A 101 to 250 Biotech Lausanne, Switzerland •••••••••••@newbiologix.com
Chord Therapeutics

Clinical-stage biopharmaceutical company developing drugs for rare diseases.

21
$16M · Series A 11 to 50 Health Tech, Biotech, Pharma B2B Geneva, Switzerland •••••••••••@chordtherapeutics.com
Qnami

Quantum sensing technology for nanoscale imaging.

21
$2M · Seed Quantonation, High-Tech Gründerfonds, Verve Ventures 11 to 50 Health Tech, Hardware, Biotech, Navigation and Mapping, Manufacturing B2B Basel, Switzerland •••••••••••@qnami.ch
Nanoflex Robotics

Medical robotics company.

21
$12M · Series A 11 to 50 Biotech Zürich, Switzerland •••••••••••@nanoflexrobotics.com
rqmicro

Pathogen detection technology that provides accurate results in under 2 hours.

21
$6M · Series B 11 to 50 Climate Tech & Green Tech, Health Tech, Biotech, Deep Tech, Energy & Nuclear, Business Intelligence B2B Zürich, Switzerland •••••••••••@rqmicro.com
Scailyte

True precision medicine through single-cell science

21
$1M · Series A Verve Ventures, Swisscom Ventures 11 to 50 Health Tech, AI, Biotech B2B Basel, Switzerland •••••••••••@scailyte.com
Virometix

Biotechnology company creating vaccines and immunotherapies.

21
$8M · Series B 11 to 50 Health Tech, Biotech B2B Zürich, Switzerland •••••••••••@virometix.com
Navignostics

Platform that identifies the ideal treatment for each cancer patient’s disease.

21
$7M 1 to 10 Health Tech, Hardware, Biotech, Deep Tech, Pharma Zürich, Switzerland •••••••••••@navignostics.com
Cimeio Therapeutics

Platform for developing curative treatments for genetic diseases, blood cancers, and severe autoimmune disorders.

20
$50M · Series A 11 to 50 Health Tech, Biotech, Pharma, Manufacturing B2B Basel, Switzerland •••••••••••@cimeio.com
T3 Pharmaceuticals

Treatments that improve the lives of cancer patients with innovative approaches.

20
$26M · Series C 1 to 10 Health Tech, Biotech, Deep Tech, Pharma B2B Basel, Switzerland •••••••••••@t3pharma.com
Vector BioPharma

Gene precision delivery platform that enhances the safety, effectiveness, and accuracy of biologic therapies.

20
$30M · Series A 11 to 50 Health Tech, Biotech, Deep Tech B2B Basel, Switzerland •••••••••••@vectorbiopharma.com
Medyria

Guided medical devices cardiovascular procedures.

18
$4M · Series B 1 to 10 Biotech Zürich, Switzerland •••••••••••@medyria.com
Testmate Health

Self-testing kit provider for quick, at-home medical results.

17
$1M · Seed Next Ventures 1 to 10 Health Tech, Biotech, Deep Tech, Pharma, Manufacturing B2B, B2C Lausanne, Switzerland •••••••••••@testmatehealth.com
NextImmune

Biotechnology company developing treatments to enhance immune system responses.

17
$154k · Pre Seed Venture Kick Health Tech, Biotech, Pharma B2B Basel, Switzerland •••••••••••@nextimmune.com
Flowbone

We engineered the first injectable biomaterial that stimulated the body's natural ossification process for rapid bone repair & strengthening

17
$166k · Pre Seed Venture Kick 1 to 10 Health Tech, Hardware, Biotech, Deep Tech, Pharma, Manufacturing, ElderTech B2B Lausanne, Switzerland •••••••••••@flowbone.com
Resistell AG

Antibiotic resistance test.

17
$9M · Series B 1 to 10 Biotech, Deep Tech Basel, Switzerland •••••••••••@resistell.com
Phialogics

Next-gen IgV therapeutics developer.

17
$656k · Pre Seed High-Tech Gründerfonds 1 to 10 Biotech Basel, Switzerland •••••••••••@phialogics.com
Adaptyv Biosystems

Protein engineering platform using cell-free synthetic biology and nanofluidics.

17
$125k · Pre Seed Y Combinator, Wingman Ventures 1 to 10 Health Tech, Biotech, Deep Tech, Manufacturing B2B Lausanne, Switzerland •••••••••••@adaptyvbio.com
Rheon Medical

Rheon focuses on the development of first-in-class glaucoma drainage devices.

17
$6M 1 to 10 Health Tech, Hardware, Biotech, Manufacturing B2B Lausanne, Switzerland •••••••••••@rheonmedical.com
Versameb

Platform focusing on the discovery and development of next-generation RNA-based drugs.

17
$6M · Seed 1 to 10 Health Tech, Biotech, Pharma B2B Basel, Switzerland •••••••••••@versameb.com
Bionomous

Device that automatically inspects and sorts miniature biological entities.

17
$166k · Pre Seed Venture Kick 1 to 10 Health Tech, Biotech, Machine Learning, Manufacturing B2B Lausanne, Switzerland •••••••••••@bionomous.ch
Vatorex

System improving honey bee health by using heat to combat the varroa mite.

15
$1M 1 to 10 Climate Tech & Green Tech, Agritech, Hardware, Biotech B2B Zürich, Switzerland •••••••••••@vatorex.ch
Aequicens

AI-powered biotech research platform.

15
$110k · Pre Seed 1 to 10 Biotech, Data and Analytics B2B, SaaS Geneva, Switzerland •••••••••••@aequicens.com
Biosimo

Chemicals company producing sustainable chemicals.

15
$308k · Pre Seed 1 to 10 Biotech, Deep Tech, Proptech & Real Estate, Manufacturing B2B Zürich, Switzerland •••••••••••@biosimo-chemicals.com
Ovomind

Platform for sharing and interacting with video games using emotions.

15
$1M 1 to 10 Gaming, Biotech, Data and Analytics, Business Intelligence B2B, SaaS Geneva, Switzerland •••••••••••@ovomind.com
Novostia

Clinical stage artificial heart valve.

14
$2M · Series A 1 to 10 Biotech B2C Bern, Switzerland •••••••••••@novostia.com
MaxWell Biosystems

Solutions that advance neuroscience research and speed up preclinical drug discovery.

14
$4M · Series A 11 to 50 Health Tech, Biotech, Manufacturing B2B Basel, Switzerland •••••••••••@mxwbio.com
Ymmunobio

Preclinical-stage oncology platform.

14
$1M · Seed 1 to 10 Health Tech, Biotech Basel, Switzerland •••••••••••@ymmunobio.com
Aspivix

Device improving comfort during gynecological procedures.

14
$5M 1 to 10 Health Tech, Hardware, Biotech, Manufacturing B2B Lausanne, Switzerland •••••••••••@aspivix.com
AERA Health

Preventive health technology.

14
$4M · Pre Seed 11 to 50 Health Tech, Biotech Basel, Switzerland •••••••••••@aera.health
Bloom Biorenewables Ltd

Bloom Biorenewables is making biomass a true alternative to petroleum.

14
$3M 1 to 10 Climate Tech & Green Tech, Biotech, Pharma, Energy & Nuclear, Manufacturing B2B Fribourg, Switzerland •••••••••••@bloombiorenewables.com
Molecule

Software platform that accelerates innovation in the pharmaceutical industry.

12
N/A BACKED VC, Speedinvest, BoxGroup 11 to 50 Health Tech, Fintech, Crypto & web3, Biotech, Deep Tech, Pharma B2B, Marketplace Schaffhausen, Switzerland •••••••••••@molecule.to
DeepSquare

The Tokenised Cloud - Sustainable, Decentralised

10
$2M · Pre Seed 11 to 50 Climate Tech & Green Tech, Health Tech, Crypto & web3, Biotech, Deep Tech, Manufacturing B2B, SaaS Zug, Switzerland •••••••••••@deepsquare.io
AC BioScience

Biotech firm focused on creating personalized molecular therapies for cancer patients.

10
$1M · Seed 11 to 50 Health Tech, Biotech B2B Lausanne, Switzerland •••••••••••@ac-bioscience.com